Krahl SE, Clark KB, Smith DC, Browning RA: Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation
Vagus nerve stimulation
(VNSTM) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.
Still, the seizure reductions in these patients--who generally had nor achieved control with medications--confirm the value of vagus nerve stimulation
Because the vagus nerve innervates the pharynx, heart, lungs, bronchi and the gastrointestinal tract, vagus nerve stimulation
can cause adverse side effects such as hoarseness, coughing, tingling, shortness of breath, nausea and dysphagia.
The FitNeS system was developed to offer a new treatment option for refractory epilepsy patients while delivering improvements over existing vagus nerve stimulation
Although vagus nerve stimulation
(VNS) and electroconvulsive therapy (ECT) are not mutually exclusive, the safety of concurrent use of these 2 therapies is uncertain.
The idea is for patients to wear a self-controlled vagus nerve stimulation
(VNS) device that can be activated the moment they experience the onset of aura to indirectly stimulate the brain and prevent an epileptic seizure.
The global electrical stimulation devices market segmentation is based on product types (Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation
(VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electrical Stimulation (GES) Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Other Devices (Electrotherapy Devices, Combination Devices, TNS, TMS, etc.
The contract includes the following product - SCS - spinal cord stimulation,- VNS - Vagus nerve stimulation
M2 PHARMA-March 3, 2015-Non-Invasive Vagus Nerve Stimulation
from ElectroCore Shown Effective for Cluster Headaches
that it would not provide coverage for the company's Vagus Nerve Stimulation
(VNS) therapy as a treatment for beneficiaries suffering from treatment-resistant depression (TRD).
No unexpected safety findings have emerged in the early phases of two postmarketing studies of the vagus nerve stimulation
device in patients with depression, according to the manufacturer.